Abstract
Protein aggregation is facilitated by the generation of partially folded intermediates that lack most of the tertiary interactions, but retain the complete secondary structure. These partially folded states cross-link each other to form protein aggregates. Protein aggregates in an advanced stage result in the formation of amyloid fibrils, which have high tensile strength. These amyloid fibrils are associated with a number of pathologies, especially Alzheimer’s disease, which involves the aggregation of the Aβ peptide. In recent years, much attention has been paid to the generation of potent therapeutics to reduce Aβ peptide fibrillation. This review summarizes the range of molecules used for this therapy, showing their potency against Aβ amyloids, and suggests a positive future for the eradication of this dreaded disease.
Keywords: Aβ peptide, Alzheimer’s disease, amyloid fibrils, protein aggregates, nanotechnological approach.
Current Drug Metabolism
Title:Therapeutic Interventions for the Suppression of Alzheimer’s Disease: Quest for a Remedy
Volume: 16 Issue: 5
Author(s): Naveed Ahmad Fazili, Aabgeena Naeem, Ghulam Md. Ashraf, Siew Hua Gan and Mohammad A. Kamal
Affiliation:
Keywords: Aβ peptide, Alzheimer’s disease, amyloid fibrils, protein aggregates, nanotechnological approach.
Abstract: Protein aggregation is facilitated by the generation of partially folded intermediates that lack most of the tertiary interactions, but retain the complete secondary structure. These partially folded states cross-link each other to form protein aggregates. Protein aggregates in an advanced stage result in the formation of amyloid fibrils, which have high tensile strength. These amyloid fibrils are associated with a number of pathologies, especially Alzheimer’s disease, which involves the aggregation of the Aβ peptide. In recent years, much attention has been paid to the generation of potent therapeutics to reduce Aβ peptide fibrillation. This review summarizes the range of molecules used for this therapy, showing their potency against Aβ amyloids, and suggests a positive future for the eradication of this dreaded disease.
Export Options
About this article
Cite this article as:
Ahmad Fazili Naveed, Naeem Aabgeena, Md. Ashraf Ghulam, Hua Gan Siew and A. Kamal Mohammad, Therapeutic Interventions for the Suppression of Alzheimer’s Disease: Quest for a Remedy, Current Drug Metabolism 2015; 16 (5) . https://dx.doi.org/10.2174/1389200215999141125115749
DOI https://dx.doi.org/10.2174/1389200215999141125115749 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Tissue Distribution and Metabolism of Micro- and Nanoparticles and Medical Implants
With the continuous advancement of modern science and engineering, numerous functional materials and active molecules have been developed and utilized in various industrial, medical, and food applications. Many of these can enter the body, either actively or passively, and have significant and intricate impacts on human health. For example, biomaterials ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Molecular Basis of Neural Memory. Part 4. “Binary” Computation vs “Multinary” Mentation
Neuroscience and Biomedical Engineering (Discontinued) One Hundred Faces of Cyclopamine
Current Pharmaceutical Design The Chemistry and Pharmacology of Tetrahydropyridines
Current Medicinal Chemistry In-hospital Falls in Older Patients: The Risk Factors and The Role of Hyponatraemia
Current Aging Science Long-term Potentiation at Spinal C-fiber Synapses: A Target for Pathological Pain
Current Pharmaceutical Design Development of Novel Amyloid Imaging Agents Based Upon Thioflavin S
Current Alzheimer Research Sirtuin Modulators: Targets for Metabolic Diseases and Beyond
Current Topics in Medicinal Chemistry Cytosine Methyltransferases as Tumor Markers
Current Genomics ‘Non-Criteria’ Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered
CNS & Neurological Disorders - Drug Targets Cordycepin Exerts Neuroprotective Effects via an Anti-Apoptotic Mechanism based on the Mitochondrial Pathway in a Rotenone-Induced Parkinsonism Rat Model
CNS & Neurological Disorders - Drug Targets History of Psychiatry in the Dominican Republic
Adolescent Psychiatry Astrocytic Signaling in Persistent Pain
Current Signal Transduction Therapy Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application
Current Neuropharmacology Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease
Current Neuropharmacology Pathophysiology of Erectile Dysfunction
Current Drug Targets Neural Induction of Adult Bone Marrow and Umbilical Cord Stem Cells
Current Neurovascular Research A Review of Calcium Pyrophosphate Deposition (CPPD)
Current Medical Imaging Cytochrome P450 and the Biological Clock in Mammals
Current Drug Metabolism Macrolides Allergy
Current Pharmaceutical Design